Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
51.80
-0.70 (-1.33%)
At close: Mar 3, 2025
-44.06%
Market Cap 5.56B
Revenue (ttm) 7.98B
Net Income (ttm) 421.76M
Shares Out 107.42M
EPS (ttm) 3.93
PE Ratio 13.19
Forward PE n/a
Dividend 1.40 (2.67%)
Ex-Dividend Date Nov 20, 2024
Volume 185,583
Average Volume 546,981
Open n/a
Previous Close 52.50
Day's Range 51.70 - 52.90
52-Week Range 36.20 - 118.90
Beta -0.15
RSI 60.52
Earnings Date Apr 13, 2025

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. The company was incorporated in 1986 and is based in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Employees 4,408
Stock Exchange Dhaka Stock Exchange
Ticker Symbol NAVANAPHAR
Full Company Profile

Financial Performance

In 2024, Navana Pharmaceuticals's revenue was 6.90 billion, an increase of 20.89% compared to the previous year's 5.71 billion. Earnings were 404.63 million, an increase of 13.36%.

Financial Statements

News

There is no news available yet.